HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models.

Joseph TorresiBang Manh TranDale ChristiansenLinda Earnest-SilveiraRenate Hilda Marianne SchwabElizabeth Vincan

Published in: BMC cancer (2019)

By utilizing new ex vivo techniques like liver organoids it will become possible to develop improved and personalized therapeutic approaches that will improve HCC outcomes and potentially lead to a cure for HBV.

Keyphrases

hepatitis b virus
liver failure
type diabetes
adipose tissue
weight loss
glycemic control